Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC
Holding CYCC?
Track your performance easily

Cyclacel Pharmaceuticals (CYCC) Financial Statements

636 Followers

Cyclacel Pharmaceuticals Financial Overview

Cyclacel Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-17.52; its P/E ratio is -0.06; Cyclacel Pharmaceuticals is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 4.00K$ 29.00K$ 31.00K$ 16.00K$ 373.00K
Gross Profit$ 4.00K$ 29.00K$ 31.00K$ 16.00K$ 373.00K
EBIT$ -3.67M$ -4.30M$ -5.36M$ -6.70M$ -6.03M
EBITDA$ -3.67M$ -4.30M$ -5.35M$ -6.69M$ -6.03M
Net Income Common Stockholders$ -3.26M$ -2.95M$ -5.32M$ -6.08M$ -5.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.00M$ 2.80M$ 3.38M$ 5.94M$ 10.16M
Total Assets$ 8.19M$ 6.17M$ 8.80M$ 12.50M$ 16.44M
Total Debt$ 5.00K$ 21.00K$ 37.00K$ 52.00K$ 66.00K
Net Debt$ -6.00M$ -2.78M$ -3.34M$ -5.89M$ -10.10M
Total Liabilities$ 7.19M$ 8.37M$ 8.20M$ 8.20M$ 6.81M
Stockholders Equity$ 999.00K$ -2.21M$ 607.00K$ 4.30M$ 5.14M
Cash Flow-
Free Cash Flow$ -3.08M$ -483.00K$ -3.91M$ -4.04M$ -1.30M
Operating Cash Flow$ -3.08M$ -483.00K$ -3.91M$ -4.04M$ -1.30M
Investing Cash Flow-----
Financing Cash Flow$ 6.29M$ -79.00K$ 999.00K$ -50.00K$ -51.00K
Currency in USD

Cyclacel Pharmaceuticals Earnings and Revenue History

Cyclacel Pharmaceuticals Debt to Assets

Cyclacel Pharmaceuticals Cash Flow

Cyclacel Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis